All posts by admin

Business Wire India

MidOcean Energy (“MidOcean” or the “Company”), a liquefied natural gas (LNG) company formed and managed by EIG, today announced an equity capital raise of more than $1.2 billion.

 

This equity raise includes:

 

 

• a $500 million commitment from Idemitsu Kosan, a highly respected global energy company with a long-standing presence across the energy value chain; and
• additional commitments of $790 million from both new and existing investors.

 

 

This represents a significant milestone in MidOcean’s capital formation program and reflects continued interest from both new and existing investors in the Company’s strategy to seek to build a diversified, resilient, long-life global LNG platform.

 

There is significant further momentum from additional investors currently in documentation. MidOcean will continue to raise capital, with a cumulative target of up to $2 billion from new investors. The Company has received substantial interest from investors seeking long-term exposure to the LNG sector, supported by strong demand fundamentals, constrained supply growth and LNG’s role in supporting energy security and the energy transition. Recent events only reinforce the strength of the MidOcean investment thesis.

 

 

De la Rey Venter, CEO of MidOcean, said: “We are delighted to welcome Idemitsu Kosan as a strategic investor in MidOcean. The success of this equity raise is a strong validation of MidOcean’s strategy, asset base and transaction pipeline. The level of participation from both new investors and our existing shareholder base signals confidence in our strategy and our company. We look forward to welcoming more investors into the company as we progress toward final close.”

 

 

Important Notice

 

 

This announcement is for information purposes only and does not constitute an offer to sell or the solicitation of an offer to subscribe for or purchase any securities. Any offering will be made only pursuant to applicable offering documents and in compliance with applicable securities laws.

 

 

About EIG

 

 

EIG is a leading institutional investor in the global energy and infrastructure sectors with $25.4 billion assets under management as of December 31, 2025. EIG specializes in private investments in energy and energy-related infrastructure on a global basis. During its 43-year history, EIG has committed over $53.4 billion to the energy sector through 425 projects or companies in 44 countries on six continents. EIG’s clients include many of the leading pension plans, insurance companies, endowments, foundations and sovereign wealth funds in the U.S., Asia and Europe. EIG is headquartered in Washington, D.C. with offices in Houston, London, Sydney, Rio de Janeiro, Hong Kong and Seoul.

 

 

About MidOcean Energy

 

 

MidOcean Energy, an LNG company formed and managed by EIG, seeks to build a diversified, resilient, cost- and carbon-competitive global LNG portfolio. It reflects EIG’s belief in LNG as a critical element of a lower carbon, competitive and more secure global energy system. MidOcean Energy has diverse LNG interests, including in LNG Canada, Gorgon LNG, Pluto LNG, QCLNG and Peru LNG. The company is headed by De la Rey Venter, a 27-year industry veteran who has held a variety of senior executive roles, including Global Head of LNG for Shell Plc.

 

 

For additional information, please visit MidOcean Energy’s website at www.midoceanenergy.com or EIG’s website at www.eigpartners.com.

 

 

 

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260316707665/en/

 

Business Wire India

1NCE, the global company offering a plug-and-play platform for creating and managing the world’s best IoT products, together with its exclusive APAC sales partner SoftBank Corp., today announced a strategic collaboration with LEOTEK, a global leader in intelligent traffic solutions. The partnership aims to accelerate the international deployment of the LEOLink Intelligent Lighting System (ILS).

 

At the 2026 Smart City Summit & Expo, the partners are showcasing a unified architecture that integrates 1NCE with LEOTEK’s AI-driven management. This allows municipalities to turn traditional street lighting into high-performance digital grids with zero-touch global deployment. By integrating the 1NCE platform, LEOTEK eliminates the need for local carrier contracts, allowing thousands of devices to be deployed instantly across 170+ countries.

 

 

1NCE’s software and connectivity platform has become a new industry standard, delivering hassle-free IoT. For LEOTEK, this means AI-driven lights can be shipped, installed, and connected instantly worldwide. “Smart infrastructure projects benefit when connectivity is simple to deploy and straightforward to operate,” said Hitoshi Ono, Senior Vice President of 1NCE. “By supporting LEOTEK’s connected lighting deployments with global cellular IoT connectivity, we help enable efficient rollout and scalable operations – so cities can focus on outcomes like improved maintenance planning and better asset visibility.”

 

 

By collaborating with 1NCE, LEOTEK can deploy AI-powered sensors and management tools worldwide without the complexity of managing local carrier contracts or roaming hurdles. Torrent Chin, President and Chief Sustainability Officer of LEOTEK, added: “By combining our intelligent lighting capabilities with global IoT connectivity, we aim to help municipalities modernize street lighting with better operational transparency and long-term efficiency.”

 

 

The integrated 1NCE and LEOTEK model is operational across high-density urban environments and critical energy projects. Deployments in Boston, Syracuse, and Fort Wayne upgraded traditional lamps to smart nodes with remote monitoring. The solution has also been adopted by the DTE Energy project in Michigan and expanded to San Francisco. Cross-border connectivity has enabled extensions across metropolitan areas in Mexico and South America.

 

 

About 1NCE

 

 

1NCE delivers the fundamental software and connectivity platform for customers to create and manage the world’s best intelligent products. The software platform enables customers to easily, securely and reliably collect device data across 170+ countries and turn it into actionable intelligence. Learn more at www.1NCE.com and follow on Facebook, LinkedIn and X.

 

 

About LEOTEK

 

 

LEOTEK, a subsidiary of LITEON Technology, is headquartered in Silicon Valley and Taipei. It is a global leader in AI-driven smart traffic and sustainable lighting solutions. Since its founding in 1992, the company has expanded its footprint to over 30 countries and 300 cities across the Americas, Europe, the Middle East, and Oceania. LEOTEK provides infrastructure solutions that integrate AI, IoT sensing, and predictive maintenance. With a vision of “Intelligent Sustainable Infrastructure,” LEOTEK continues to lead cities toward a safer, greener, and net-zero future.

 

 

For more information, please visit: https://leotek.com/, Linkedin

 

 

 

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260315648992/en/

 

Business Wire India

• Galderma will present nine posters spanning its full aesthetics portfolio at AMWC 2026, highlighting the regenerative benefits of Sculptra^®, the long-lasting efficacy of Restylane^®, and the advanced clinical performance of Relfydess^® (RelabotulinumtoxinA) ^1-9
• The data reinforce Galderma’s future-focused approach to innovation, addressing emerging patient needs from menopause‑related skin changes to rising interest in body injectables and regenerative treatments
• A series of symposia and Masterclasses will further highlight Galderma’s leadership in aesthetics, showcasing how the portfolio supports complex patient profiles and evolving global trends

 

Galderma (SIX: GALD) will present nine abstracts at the Aesthetic & Anti‑Aging Medicine (AMWC) World Congress 2026 in Monaco, showcasing innovative and robust scientific data across its aesthetics portfolio, alongside three symposia, and multiple Masterclasses and Meet‑the‑Expert sessions, all highlighting the expanding benefits of Sculptra, Relfydess and the Restylane range.^1-9 This comprehensive scientific presence reflects Galderma’s holistic, trend‑led approach to innovation, and its commitment to addressing emerging needs such as menopause‑related skin changes, the growing interest in regenerative treatments, and the rising demand for body injectables.

 

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260316497387/en/

 

“Patients’ needs are changing faster than ever, whether that’s navigating the skin changes associated with menopause, seeking regenerative benefits, or looking for aesthetic harmony beyond the face. The data we’re presenting at AMWC highlight how our portfolio is uniquely positioned to meet these expectations with effective and holistic treatment regimens. At Galderma, we’re committed to leading the industry with innovations that reflect real-world patient priorities.”

 

BILL ANDRIOPOULOS, PH.D.
HEAD OF GLOBAL MEDICAL AFFAIRS
GALDERMA

 

Relfydess: consistent efficacy across patient profiles and new insights into real-world value
Galderma will share new economic modelling data, reflecting real‑world experience of Relfydess from aesthetic clinics across multiple markets.¹ The analysis shows that switching from traditional powder toxins to Relfydess’ ready‑to‑use formulation could generate an annual profit increase, driven by faster onset, longer duration, higher patient satisfaction and therefore increased capacity for new appointments.¹

 

Data demonstrating Relfydess’ equally strong efficacy in both toxin‑naïve and previously treated patients will also be shared, showing high response rates, rapid onset from Day 1 and sustained improvements through six months.² Galderma will also present expert‑led consensus recommendations that address key unmet needs in real‑world clinical practice, offering clear, practical guidance for optimal dosing, injection patterns and treatment planning with Relfydess across the upper face.³

 

Comprehensive data showcase innovation and best practice across Sculptra and certain Restylane treatments for face and body
Results from an expert review will be presented, reinforcing Sculptra’s ability to deliver regenerative benefits across all three skin layers, by activating fibroblasts and stimulating the production of type I collagen, elastin, proteoglycans and other extracellular matrix components, while influencing local adipose tissue.⁴ These effects underpin the long‑term improvements seen with Sculptra, including increased elasticity, skin thickness, and overall improvements in the mechanical properties of the skin.⁴

 

In the wake of the EU MDR certification of Sculptra expanding its use to the body, guidance developed by 13 international experts will be shared at AMWC.⁵ The guidance is designed to support safe practice for comprehensive body rejuvenation, providing standardized injection protocols for or Sculptra in the posterior thighs, upper arms and gluteal area, as well as the décolletage, where its benefits can be complemented with Restylane Skinboosters^TM .⁵ Additional data evaluating the effectiveness and safety of Restylane Skinboosters for correction of moderate-to-severe wrinkles in the décolletage will also be shared, highlighting the product was well tolerated and highly efficacious, with high patient satisfaction.⁶

 

In a dedicated symposium, international experts will explore this topic further, discussing best practices for use of Sculptra, Restylane Skinboosters and Alastin™ for body indications. The session will explore patient assessment, treatment planning, and practical approaches to optimizing outcomes, with live injections to provide real-time insight into techniques and clinical decision-making. The symposium will take place Thursday, March 26, from 2:00 – 4:00 PM CET, in Camille Blanc.

 

Additional data from Galderma’s versatile Restylane hyaluronic acid (HA) injectable range in the face will also be presented.^7.8 Restylane Lyft™ demonstrated non‑inferiority to a comparator HA injectable for chin profile improvement at Month 3, and sustained aesthetic improvement and subject satisfaction through Month 12.⁷ Meanwhile, Restylane Volyme™ was shown to be well tolerated and effective for correcting temple hollowing, delivering high and long‑lasting aesthetic results through Month 18 alongside strong patient satisfaction.⁸

 

Empowering clinicians with evidence-based guidance for increasingly complex patient profiles
At the congress, Galderma will share insights into complex patient profiles, including findings from a global survey of over 4,300 women across five continents linking menopause to several skin changes, such as wrinkles, loss of firmness, dryness and dull skin, and the growing relevance of aesthetic treatments in addressing these concerns.⁹

 

This, and other complex profiles will be explored in depth in a symposium titled ‘The AART of Precision Aesthetics’ on Thursday, March 26, from 10:30 AM to 12:30 PM CET, in Prince Pierre. Focusing on groups such as menopausal patients and those affected by medication‑driven weight loss, the session, including live injections, will encourage physicians to rethink treatment planning to answer to these increasing patient needs and explore the key trends shaping the aesthetics industry.

 

A medical symposium, titled ‘A Holistic Approach to Skin Quality’ [TBC], will take place on Friday, March 28, from 11:00 AM – 12:00 PM CET, in Genevoix. The session will feature new data on menopause and addressing medication-driven weight loss on the body, and will explore the clinical principles behind Galderma’s holistic treatment philosophy, examining how skin quality interventions can be integrated for personalised, high impact results.

 

More information about Galderma’s activities at AMWC 2026 can be found here.

 

About Sculptra
Sculptra is the first proven regenerative biostimulator, with a unique poly-L-lactic acid (PLLA-SCA™) formulation, to provide progressive and sustained regenerative effect across all three skin layers.^10-17 Sculptra reverses aging processes in the skin, including degradation of the extracellular matrix, which results in volume loss, laxity, and the appearance of wrinkles.^10-12,18-20 Sculptra progressively rebuilds the skin’s structural foundation by encouraging the remodeling of components of the extracellular matrix, such as elastin and collagen, helping to gradually restore natural volume, firmness, radiance and overall skin quality, and the look of fullness to wrinkles and folds over time.^10-12,21-25 Sculptra has been shown to provide visible improvements as early as one month after treatment, with results lasting up to two years.^{10,16,23,25,26}

 

About the Restylane portfolio
Restylane HA treatments are designed differently to go beyond volumizing for natural-looking results.^27-30 Our HA is minimally modified and our innovative manufacturing process preserves its biocompatibility while creating individual products designed for a specific purpose.^31-34 Powered by NASHA^®, NASHA HD™, OBT™ and SB-NASHA™ technologies, Restylane offers a range of gels from the highest firmness to the highest flexibility, enabling personalized treatments that deliver structural support, natural-looking results, and a healthy glow.^35-38 Trusted for almost three decades, our HA gels work in sync with your skin for 100% natural-looking results.^27,39,40

 

About Relfydess (RelabotulinumtoxinA)
Pioneered by Galderma, Relfydess is the first and only ready-to-use liquid neuromodulator created with PEARL Technology that is designed to preserve molecule integrity.⁴¹ PEARL Technology is designed to deliver a highly active, innovative, complex-free molecule, with up to 39% of patients seeing effects from day one and up to 75% of patients maintaining improvements for six months.^41-43 Relfydess is optimized for simple volumetric dosing, without reconstitution, to increase ease-of-use and help ensure consistent dose/volume every time. ^44,45 It was entirely created and manufactured by Galderma to expand its neuromodulator portfolio as part of the broadest Injectable Aesthetics portfolio on the market. Relfydess has received a marketing authorization in many markets. Authorization conditions vary internationally.

 

About Galderma
Galderma (SIX: GALD) is the pure-play dermatology category leader, present in approximately 90 countries. We deliver an innovative, science-based portfolio of premium flagship brands and services that span the full spectrum of the fast-growing dermatology market through Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology. Since our foundation in 1981, we have dedicated our focus and passion to the human body’s largest organ – the skin – meeting individual consumer and patient needs with superior outcomes in partnership with healthcare professionals. Because we understand that the skin we are in shapes our lives, we are advancing dermatology for every skin story. For more information: www.galderma.com.

 

References

 

1. Milotich A, et al. Economic potential of a next-generation ready-to-use liquid formulation of relabotulinumtoxin type A. Poster presented at AMWC 2026; March 26-28, 2026; Monaco
2. Grunebaum L D, et al. RelabotulinumtoxinA treatment improved moderate-to-severe glabellar lines and lateral canthal lines regardless of baseline toxin naivety: subgroup analyses of pooled Phase 3 study data. Poster presented at AMWC 2026; March 26-28, 2026; Monaco
3. Chadha P, et al. Consensus recommendations on the aesthetic use of relabotulinumtoxinA to treat upper face wrinkles. Poster presented at AMWC 2026; March 26-28, 2026; Monaco
4. Fabi S, et al. Regenerative aesthetic effects of poly L-lactic acid treatment. Poster presented at AMWC 2026; March 26-28, 2026; Monaco
5. Haddad A, et al. International consensus: PLLA-SCA/SB-NASHA for non-facial rejuvenation. Poster presented at AMWC 2026; March 26-28, 2026; Monaco
6. Fabi S, et al. Effectiveness and safety of a hyaluronic acid skin quality injectable for the correction of wrinkles in the décolletage area. Poster presented at AMWC 2026; March 26-28, 2026; Monaco
7. Ablon G, et al. A randomized, comparator-controlled trial to evaluate a hyaluronic acid filler for augmentation of the chin region. Poster presented at AMWC 2026; March 26-28, 2026; Monaco
8. Nestor M, et al. Safety and effectiveness of an OBT™ hyaluronic acid filler for temple hollowing treatment: a randomized, controlled, clinical investigation. Poster presented at AMWC 2026; March 26-28, 2026; Monaco.
9. Nikolis A, et al. The potential role of biostimulators/dermal fillers to address menopause-related skin conditions. Poster presented at AMWC 2026; March 26-28, 2026; Monaco
10. Sculptra^®. EU Instructions for Use. 2025. Available online. Accessed January 2026.
11. Waibel J, et al. Bulk RNA-seq Analysis of Poly-L-Lactic Acid (PLLA-SCA) vs Calcium Hydroxyapatite (CaHA-R) Reveals a Novel, Adipocyte Mediated Regenerative Mechanism of Action Unique to PLLA. Poster presented at ASDS 2024 Annual Meeting; October 17-20, 2024; Orlando, Florida, United States.
12. Waibel J, et al. Gene Analysis of Biostimulators: PLLA-SCA Triggers Regenerative Morphogenesis while CaHA-R Induces Inflammation upon Facial Injection. Poster presented at ASDS 2024 Annual Meeting; October 17-20, 2024; Orlando, Florida, United States.
13. Huth S, et al. Molecular Insights into the effects of PLLA_SCA on Gene Expression and Collagen Synthesis in Human 3D Skin Models Containing Macrophages. J Drugs Dermatol. 2024;23(4):285–288. doi: 10.36849/JDD.7791.
14. Galderma. Data on File. MA-46589.
15. Vleggaar D, et al. Consensus recommendations on the use of injectable poly-L-lactic-acid for facial and nonfacial volumization. J Drugs Dermatol. 2014;13(4 Suppl):s44–s51.
16. Widgegrow J, et al. A randomized, comparative study describing the gene signatures of poly-l-lactic acid (PLLA-SCA) and Calcium Hydroxyapatite (CaHA) in the treatment of nasolabial folds. Poster presented at IMCAS World Congress; February 1-3, 2024. Paris, France.
17. Duracinsky M, et al. Safety of poly-L-lactic acid (New-Fill^®) in the treatment of facial lipoatrophy: a large observational study among HIV-positive patients. BMC Infect Dis. 2014;14(474). doi: 10.1186/1471-2334-14-474.
18. Zhang S and Duan E. Fighting against Skin Aging: The Way from Bench to Bedside. Cell Transplant. 2018;27(5):729–738. doi: 10.1177/0963689717725755.
19. Shuster S, et al. The influence of age and sex on skin thickness, skin collagen and density. Br J Dermatol. 1975;93(6):639-43. doi: 10.1111/j.1365-2133.1975.tb05113.x.
20. Zarbafian M, et al. The emerging field of regenerative aesthetics—where we are now. Dermatol Surg. 2022;48:101–108. doi: 10.1097/DSS.0000000000003239.
21. Galderma. Data on File. MA-57540.
22. Nikolis A, et al. A Prospective, Multicenter Trial on the Efficacy and Safety of Poly-L-Lactic Acid for the Treatment of Contour Deformities of the Buttock Regions. J Drugs Dermatol. 2022;21(3):295–303. doi: 10.36849/JDD.5924.
23. Beleznay K, et al. Safety and Effectiveness of Poly-L-lactic acid (PLLA-SCA) for the Improvement in Appearance of Cellulite – A Pilot Study. Poster presented at the IMCAS World Congress; February 1-3, 2024; Paris, France.
24. Mazzuco R, et al. Clinical and Histological comparative outcomes after injections of Poly-L-Lactic Acid and Calcium Hydroxyapatite in arms – a split side study. J Cosmet Dermatol. 2022;21(12):6727–6733. doi: 10.1111/jocd.15356. Epub 2022 Sep 20.
25. Fabi S, et al. 24-month clinical trial data on effectiveness and safety after correction of cheek wrinkles using a biostimulatory poly-L-lactic acid injectable implant. Poster presented at IMCAS World Congress; January 26-28, 2023; Paris, France.
26. Goldberg D, et al. Single-arm study for the characterization of human tissue response to injectable poly-L-lactic acid. Dermatol Surg. 2013;39(6):915–922. doi: 10.1111/dsu.12164.
27. Di Gregorio C, et al. 25+ years of experience with the Restylane portfolio of injectable HA fillers for facial aesthetic treatment. E-poster presented at AMWC; March 27-29, 2024; Monaco.
28. Nikolis A, et al. The role of clinical examination in midface volume correction using hyaluronic acid fillers: should patients be stratified by skin thickness? Aesthet Surg J Open Forum. 2020;2(1):1–12. doi: 10.1093/asjof/ojaa005.
29. Talarico S, et al. High patient satisfaction of a HA filler producing enduring full-facial volume restoration: an 18- month open multicenter study. Dermatol Surg. 2015;41:1361–1369. doi: 10.1097/DSS.0000000000000549.
30. Restylane. U.S. Instructions for use. Available online. Accessed March 2026.
31. Edsman K, et al. Gel properties of hyaluronic acid dermal fillers. Dermatol Surg. 2012;38:1170–1179. doi: 10.1111/j.1524-4725.2012.02472.x.
32. Galderma. Data on file. MA-58650. Degree of modification of HA fillers.
33. Seo K. Facial volumization with fillers. Springer. 2021;29–83. https://doi.org/10.1007/978-981-33-6212-3_2.
34. Kablik J, et al. Comparative physical properties of hyaluronic acid dermal fillers. Dermatol Surg. 2009:35S(1):302–312. doi: 10.1111/j.1524-4725.2008.01046.x.
35. Galderma Data on file. MA-56724. X-strain and G’ including Shaype.
36. Nikolis A, et al. Effectiveness and Safety of a New Hyaluronic Acid Injectable for Augmentation and Correction of Chin Retrusion. J Drugs Dermatol. 2024;23(4):255–261. doi: 10.36849/JDD.8145.
37. Öhrlund Å et al. Differentiation of NASHA and OBT Hyaluronic Acid Gels According to Strength, Flexibility, and Associated Clinical Significance J Drugs Dermatol. 2024;23(1):1332–1336. doi: 10.36849/JDD.7648.
38. Belmontesi M et al. Injectable Non-Animal Stabilized Hyaluronic Acid as a Skin Quality Booster: An Expert Panel Consensus J Drugs Dermatol. 2018;17(1):83–88.
39. Solish N, et al. Dynamics of HA fillers formulated to maintain natural facial expression. J Cosmet Dermatol. 2019;18(3):738-746. doi: 10.1111/jocd.12961.
40. Philipp‐Dormston WG, et al. Perceived naturalness of facial expression after HA filler injection in nasolabial folds and lower face. J Cosmet Dermatol. 2020;19(7):1600-1606. doi: 10.1111/jocd.13205.
41. Shridharani SM, et al. Efficacy and safety of RelabotulinumtoxinA, a new ready-to-use liquid formulation botulinum toxin: Results from the READY-1 double-blind, randomized, placebo-controlled phase 3 trial in glabellar lines. Aesthet Surg J. 2024;44(12):1330-1340. doi: 10.1093/asj/sjae131.
42. Ablon G, et al. Treatment of lateral canthal lines with RelabotulinumtoxinA, an investigational liquid botulinum toxin: clinical efficacy and safety results from the READY-2 phase 3 trial. Toxicon. 2024;237(1):107353. doi: 10.1026/j.toxicon.2024.107353.
43. Relfydess^®. EU Summary of Product Characteristics.
44. Sundberg AL and Stahl U. Relabotulinum toxin – a novel, high purity BoNT-A1 in liquid formulation. Presented at TOXINS; January 16-17, 2021; virtual meeting.
45. Do M, et al. Purification process of a complex-free highly purified botulinum neurotoxin type A1 (BoNT-A1) – relabotulinumtoxinA. Presented at TOXINS; July 27-30, 2022; Louisiana, United States.

 

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260316497387/en/

 

Business Wire India

H.U. Group Holdings Inc., and its wholly owned subsidiary, Fujirebio Holdings, Inc. (hereinafter “Fujirebio”) today announced that Fujirebio Europe N.V. has obtained a CE Certificate of the Lumipulse G NfL Blood assay under the Regulation (EU) 2017/746 on in vitro diagnostic medical devices (IVDR). This CLEIA (chemiluminescent enzyme immunoassay) test allows for the quantitative measurement of Neurofilament light chain (NfL) in plasma and serum.

 

“While our assay menu already features many powerful disease-specific biomarkers, NfL marks a major breakthrough: our first CE-marked blood test that empowers clinicians with insights across a wide range of neurological disorders,” said Christiaan De Wilde, CEO at Fujirebio Europe N.V. “We are excited to bring this test to our customers, further expanding our comprehensive portfolio of fully automated neurological disease testing solutions on the LUMIPULSE G platform. We continue to partner with organizations and clinical experts across the world to enable earlier, easier and more complete neurological disease diagnostic tools.”

 

 

About NfL

 

 

Neurofilament light chain (NfL) is a biologically relevant biomarker of neuroaxonal injury that can support disease monitoring, prognosis, and treatment evaluation across a wide range of neurological disorders. Its clinical utility depends on interpretation within the appropriate clinical context, using age-related ref values, well-defined clinical decision rules, and longitudinal assessment of change over time.

 

 

Advances in sensitive and fully automated immunoassays have enabled reliable quantification of NfL in serum and plasma, supporting its transition from a research marker to a clinically relevant tool. Across neurodegenerative diseases of different etiologies – inflammatory, vascular, infectious, and traumatic conditions – elevated NfL levels consistently reflect axonal damage largely independent of underlying pathogenic mechanisms.

 

 

About Fujirebio

 

 

Fujirebio is a diagnostics company with over 75 years of experience delivering innovative solutions to healthcare providers, pharmaceutical companies, and in vitro diagnostics (IVD) partners worldwide. Leveraging world-class expertise in neurology, oncology, infectious diseases, and beyond, and assays available on the robust LUMIPULSE^® G platform, Fujirebio’s open business model accelerates access to breakthrough diagnostics through strategic partnerships across the life science industry.

 

 

Part of H.U. Group, Fujirebio combines strong R&D capabilities, regulatory expertise, and scalable manufacturing to deliver high-impact diagnostic solutions. Fujirebio’s flexible CDMO model helps its diagnostic partners bring validated solutions to the market faster—driving better decisions, treatments, and patient outcomes.

 

 

More information can be found at www.fujirebio.com.

 

 

 

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260316411567/en/

 

Business Wire India

Kioxia Corporation today announced the successful demonstration of achieving high-dimensional vector search scaling to 4.8 billion vectors on a single server with its open-source KIOXIA AiSAQ™ approximate nearest neighbor search (ANNS) technology. Additionally, Kioxia demonstrated a significant reduction in index build time by leveraging GPU acceleration through NVIDIA cuVS. These two achievements mark a significant advancement for retrieval augmented generation (RAG) search solutions. Continued development is underway to support larger-scale deployments beyond 4.8 billion vectors.

 

Index build time on a massive-scale vector database is a crucial pain point for the industry. In collaboration with NVIDIA, Kioxia demonstrated up to 20x improvement in KIOXIA AiSAQ index build time for high-dimensional vectors of 1024 dimensions, and up to 7.8x improvement in end-to-end build times. This 20x improvement represents a reduction from 28.4 days using CPU to 1.4 days using four NVIDIA Hopper GPUs to build the index, and a reduction from 31 days to 4 days in end-to-end testing.¹

 

 

AI applications may now rely on larger volumes of vectorized information reaching tens of billions of vectors and beyond stored on SSDs, while DRAM alone becomes impractical even at a billion scale. Kioxia enables a highly scalable storage architecture with KIOXIA AiSAQ technology by achieving billion-scale search, exceeding RAG application latency requirements using a single query server in a Milvus vectorDB environment powered by GPU acceleration on index builds that make large scale deployments practical.

 

 

“Vector databases provide a backbone for applications that need to understand intent, context, and similarity across massive, unstructured datasets in real time,” said Jason Hardy, Vice President, Storage Technologies, NVIDIA. “By leveraging GPU-accelerated indexing with the NVIDIA cuVS library, Kioxia supports high-dimensional vector databases that can scale and build indexes with unprecedented efficiency.”

 

 

First announced last year, KIOXIA AiSAQ open-source software technology addresses RAG scalability challenges by enabling vector search directly from SSDs, with reduced DRAM usage. KIOXIA AiSAQ technology provides high scalability, making it well-suited for both multi-tenant environments and large-scale monolithic index deployments. The technology leverages an innovative Global Index algorithm that combines hybrid clustering and graph search to deliver efficient vector search at extreme scale. With flexible tuning options to balance performance and high-volume vector scalability, KIOXIA AiSAQ software makes large-scale deployments more accessible and easier to expand.

 

 

“Scaling vector databases into the billions requires rethinking both memory and compute,” said Masashi Yokotsuka, Managing Executive Officer, Vice President, SSD Division, Kioxia Corporation. “By combining KIOXIA AiSAQ SSD-based vector search with NVIDIA GPU acceleration for index construction, we provide practical index build at high scale deployments. As industry innovators, we will continue to push the boundaries of AI using flash memory.”

 

 

​​Kioxia remains committed to advancing storage-driven AI solutions that support intelligent data processing at scale and continues to evolve KIOXIA AiSAQ toward trillion-vector deployments.

 

 

Link to download KIOXIA AiSAQ open-source software: https://github.com/kioxia-jp/aisaq-diskann.

 

 

Notes:

1. A total of 19.66 TB of vector data was processed for this benchmark. Performance or benchmark results may vary depending on the host device, read and write conditions, data sizes and other factors.

KIOXIA AiSAQ is a trademark of KIOXIA.

Company names, product names, and service names may be trademarks of third-party companies.

 

About Kioxia

 

Kioxia is a world leader in memory solutions, dedicated to the development, production and sale of flash memory and solid-state drives (SSDs). In April 2017, its predecessor Toshiba Memory was spun off from Toshiba Corporation, the company that invented NAND flash memory in 1987. Kioxia is committed to uplifting the world with “memory” by offering products, services and systems that create choice for customers and memory-based value for society. Kioxia’s innovative 3D flash memory technology, BiCS FLASH™, is shaping the future of storage in high-density applications, including advanced smartphones, PCs, automotive systems, data centers and generative AI systems.

 

 

Information in this document, including product prices and specifications, content of services and contact information, is correct on the date of the announcement but is subject to change without prior notice.

 

 

 

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260316193136/en/

 

Business Wire India

Cadence, a global leader in computational software, today announced the appointment of Dr. Alok Jain as the managing director for the India region. In this role, Dr. Jain will spearhead Cadence’s strategic growth in the region, focusing on scaling operations, fostering innovation, and strengthening collaborations with the Indian government, academia, and industry to advance the country’s semiconductor ecosystem.

 

“India is a vital hub for Cadence’s R&D and global growth strategy,” said Anirudh Devgan, President and CEO of Cadence. “Alok’s deep technical expertise, coupled with his decades of leadership at Cadence, makes him the ideal leader to drive our India operations, a vital hub for Cadence’s R&D and global growth strategy. His contributions have been instrumental in shaping our success in India, and I am confident that under his leadership, we will continue to accelerate innovation and deepen our engagement with the thriving Indian semiconductor ecosystem.“

 

Dr. Jain brings over 35 years of industry experience and technical expertise. He joined Cadence India in 1997 and currently serves as vice president in the System Verification Group (SDA). Over the years, along with the leadership team, he has shaped the culture and growth of Cadence’s Noida site, driving teams to deliver cutting-edge solutions for customers worldwide. His leadership and commitment to technology have consistently advanced innovation within the organization.

 

Widely recognized within the technical community, Dr. Jain has represented industry bodies such as IESA and the VLSI Society of India. He holds a bachelor of technology degree in electrical engineering from the Indian Institute of Technology, Delhi. He also earned MS and PhD degrees in electrical and computer engineering from Carnegie Mellon University. Dr. Jain has authored over 30 technical papers and holds 10 patents in formal and functional verification.

 

India is a critical hub for the company, with over 30% of Cadence’s global workforce based in the country. A significant percentage of the teams in India are involved in core R&D and product development. For the last 12 years, Cadence has featured in the top 100 in the “India’s Best Companies to Work For” survey conducted by the Great Place to Work (GPTW) Institute.

 

As an early entrant into India, having established its presence in 1987, Cadence has been a foundational player in building the Indian semiconductor ecosystem, including as a founding member of the India Electronics and Semiconductor Association (IESA). Cadence has partnered with MeitY, AICTE, IITs, and other Tier 1 institutions, and over 400 colleges and universities to build a strong chip-design talent pipeline. Through initiatives such as Chips to Startup (C2S) and India-led AI-driven design innovations, Cadence is advancing India’s semiconductor mission while accelerating global innovation. Dr. Jain will play a key role in advancing Cadence’s strategic involvement in such programs of national importance.

Business Wire India

As artificial intelligence moves rapidly from experimentation to enterprise adoption, it is reshaping not only how work gets done but also what leadership looks like across industries. According to McKinsey & Company, generative AI could automate or augment up to 60-70% of tasks across knowledge-based roles, fundamentally changing how professionals work. Similarly, research from the Boston Consulting Group suggests that organisations integrating AI into decision-making and operations are already seeing productivity gains of 30-40% in certain functions, particularly in marketing, operations, and customer analytics.

 

New research conducted by CyberMedia Research and Scaler highlights the scale of this transition. The study found that 88% of engineers and recruiters expect AI to significantly change job roles within the next two to three years. At the same time, while 89% of professionals believe they are AI-ready, only 19% are deeply engaged in real AI or machine learning work, revealing a widening gap between confidence and capability.

 

As AI becomes embedded across functions such as marketing, finance, product strategy, and operations, the challenge is no longer access to AI tools but the ability to use them meaningfully. Companies increasingly need leaders who can combine strong business fundamentals with an understanding of AI and technology, bridging strategic thinking with technological capability.

 

To address this emerging leadership skills gap, Scaler recently introduced its PGP in Business & AI, a 12-month online master’s certificate programme designed for working professionals preparing for management and leadership roles in a technology-driven economy. Building on over a decade of experience training engineers and professionals in advanced technology skills, Scaler brings deep expertise in teaching complex technical concepts through industry-led instruction and hands-on learning. Scaler has also committed INR 50 crore over the next two years to scale the programme, expand industry partnerships, and deepen applied learning infrastructure.

 

“AI is fundamentally reshaping how organisations operate. The leaders who will succeed in this environment are those who combine strong business fundamentals with fluency in data, technology, and AI-driven decision making,” said Abhimanyu Saxena, Co-founder of Scaler and InterviewBit. “Management education needs to evolve accordingly. Leaders can no longer operate purely from a strategy perspective without understanding the technologies shaping their industries. This gap between technological change and leadership readiness is precisely what programmes like Scaler’s Online PGP in Business & AI aim to address.”

 

Scaler’s Online PGP in Business and AI blends core management education with technology awareness and applied AI concepts. The programme begins with a foundation phase covering structural thinking, data analysis, business communication, research, and quantitative methods, before moving into a management mastery stage that explores strategy, finance, marketing, economics, operations, and team management. Learners are then introduced to AI fundamentals, including how modern AI systems work from transformers and embeddings to reasoning models, and how these technologies can be applied safely and effectively in real business contexts. The programme culminates in a major industry capstone project in which participants work on real business challenges sourced from enterprise partners, spanning go-to-market strategy, digital operations, customer intelligence, and growth strategy.

 

Designed as an upskilling programme for working professionals, the curriculum emphasises hands-on learning through real-world assignments, decision labs, projects, and mentorship from industry leaders. Learners also gain access to Scaler’s AI-powered learning assistant and to the founders and industry networks to help them transition into management and leadership roles.

 

To maintain a high level of interaction and mentorship, the programme follows a highly selective cohort-based model, admitting only 50 learners per batch. Participants go through a structured admissions process to ensure a strong mix of professionals across technology, consulting, product, and business roles. By limiting cohort size, Scaler aims to enable deeper faculty engagement, collaborative peer learning, and more personalised mentorship throughout the programme.

 

The Scaler-CMR study also shows that professionals increasingly prefer learning models that mirror real workplace demands. More than 80% of learners prioritise hands-on projects, while recruiters place greater emphasis on real-world problem-solving and project experience over theoretical knowledge when evaluating candidates.

 

As AI continues to reshape industries, the future of leadership will increasingly belong to professionals who can bridge business strategy, data, and technology. Programmes that integrate these capabilities into management education will play an important role in preparing professionals for the next decade of business leadership.

Business Wire India

Kioxia Corporation today announced the development of its Super High IOPS SSD, a new type of SSD enabling the GPU to directly access high-speed flash memory as an expansion to High Bandwidth Memory (HBM) in AI systems. The new Super High IOPS SSD, the KIOXIA GP Series, is purpose-built to meet the growing performance demands of AI and high-performance computing, providing larger GPU-accessible memory capacity for faster data access to AI workloads. Evaluation samples of KIOXIA GP Series will be available to select customers by the end of 2026.

 

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260316827516/en/

 

 

 

The NVIDIA Storage-Next initiative addresses the anticipated shift from compute-intensive to data-intensive workloads and the expanded need for GPU-accessible memory space, currently limited by HBM size. Expanding the GPU’s usable memory space allows access to larger data sets and improves GPU utilization by moving more data closer to compute resources.

 

The NVIDIA Storage-Next initiative calls on SSD vendors to design drives optimized for GPU-initiated AI workloads. The initiative effectively expands HBM capacity by enabling GPUs to access flash-based memory. Kioxia is supporting NVIDIA’s initiative with the KIOXIA GP Series SSDs, which utilize low-latency, high-performance KIOXIA XL-FLASH™ Storage Class Memory, and is uniquely positioned for this architecture, delivering higher IOPS, finer-grained data access (512 bytes), and lower power consumption per IO, compared with Kioxia conventional TLC SSDs.

 

 

“Kioxia fully supports the NVIDIA Storage-Next initiative and will deliver purpose-built SSDs to effectively address the need for GPU-accessible memory,” said Makoto Hamada, Senior Director of the SSD Division, Kioxia Corporation. “This collaboration is instrumental in shaping the future of AI storage architecture.”

 

 

Kioxia reaffirms its commitment to driving technological advancements in AI and high-performance computing through ongoing innovation and strategic collaborations. The KIOXIA GP Series SSD family is designed to address the evolving needs of AI workloads.

 

 

Additionally, AI models are rapidly scaling toward trillions of parameters while context windows expand to millions of tokens, driving an unprecedented growth in KV (Key Value) cache requirements. Architectures such as NVIDIA’s Context Memory Storage (CMX) recognize the need to extend the memory hierarchy beyond GPU memory using high-performance storage. The KIOXIA CM9 Series PCIe^® 5.0 E3.S SSD, offering 25.6 TB TLC capacity with 3 DWPD endurance, provide the performance, capacity, and endurance needed to support these large-scale inference environments. KIOXIA believes this class of storage will play a critical role in scaling efficient, cost-optimized AI inference infrastructure. Samples will begin shipping in Q3 2026.

 

 

KIOXIA will be demonstrating the Super High IOPS SSD emulator and other technology innovations at NVIDIA GTC, booth 3522.

 

 

Notes:

 

 

Product image may differ from the actual product.

 

 

NVIDIA and Storage-Next are trademarks and/or registered trademarks of NVIDIA Corporation in the U.S. and other countries.

 

 

PCIe is a registered trademark of PCI-SIG.

 

 

Other company names, product names, and service names may be trademarks of third-party companies.

 

 

Definition of SSD capacity: Kioxia Corporation defines a kilobyte (KB) as 1,000 bytes, a megabyte (MB) as 1,000,000 bytes, a gigabyte (GB) as 1,000,000,000 bytes, a terabyte (TB) as 1,000,000,000,000 bytes, and a kibibyte (KiB) is 1,024 bytes. A computer operating system, however, reports storage capacity using powers of 2 for the definition of 1GB = 2^30 bytes = 1,073,741,824 bytes and 1TB = 2^40 bytes = 1,099,511,627,776 bytes and therefore shows less storage capacity. Available storage capacity (including examples of various media files) will vary based on file size, formatting, settings, software and operating system, and/or pre-installed software applications, or media content. Actual formatted capacity may vary.

 

 

About Kioxia

 

 

Kioxia is a world leader in memory solutions, dedicated to the development, production and sale of flash memory and solid-state drives (SSDs). In April 2017, its predecessor Toshiba Memory was spun off from Toshiba Corporation, the company that invented NAND flash memory in 1987. Kioxia is committed to uplifting the world with “memory” by offering products, services and systems that create choice for customers and memory-based value for society. Kioxia’s innovative 3D flash memory technology, BiCS FLASH™, is shaping the future of storage in high-density applications, including advanced smartphones, PCs, automotive systems, data centers and generative AI systems.

 

 

Information in this document, including product prices and specifications, content of services and contact information, is correct on the date of the announcement but is subject to change without prior notice.

 

 

 

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260316827516/en/

 

Business Wire India

NetApp® (NASDAQ: NTAP), the Intelligent Data Infrastructure company, today announced enhancements to its enterprise-grade data platform, enabling customers to remove roadblocks to AI innovation. In addition to supporting the latest innovations from NVIDIA announced at GTC, NetApp is launching NetApp AI Data Engine (AIDE)—a secure, unified AI data platform stack co-engineered with NVIDIA and integrated with the NVIDIA AI Data Platform reference design.

 

A foundational challenge for AI is enabling enterprises to discover, understand, and govern the data they have across their global data estates. If data is AI’s fuel, finding and using the best data is essential to making truly transformative AI. NetApp AIDE helps enterprises solve this need through an automatically created—and continuously updated—global metadata catalog with powerful search capabilities. Critically, the NetApp AIDE metadata catalog goes beyond standard file system metadata and actively analyzes file content to semantically enrich metadata in place, rather than introducing additional security concerns and expense by moving the data multiple times. This enriched metadata enables enterprises to find, curate, use, and govern data in order to feed and use the correct and most up-to-date data throughout the AI data pipeline—from selection and transformation through retrieval and serving to AI applications and agents.

 

 

“Despite massive investments and market pressures to leverage AI for improved productivity and enhanced business decision making, data challenges are bottlenecking projects before they even reach production,” said Syam Nair, Chief Product Officer at NetApp. “To take back control of their data, customers need a mature enterprise-grade data platform that was designed disaggregated and intelligent from the beginning so that storage, services, and control scale independently without lock-in. Leveraging the NetApp data platform, including NetApp AIDE and support for NVIDIA’s leading AI capabilities, we’re helping customers build enterprise grade AI factories supported by our high-performance unified storage platform.”

 

 

NetApp AIDE will be launching this month for an initial wave of lighthouse customers and partners, with broad availability coming early summer. As a strong champion of open technology ecosystems NetApp will also continue to deliver integrations across a number of ISV partners, both on-premises and in the cloud, providing the deep and seamless integrations essential for customers bringing production AI workloads to life. Examples of these ISV partner integrations that will be available very soon include leading AI app development platforms and frameworks built on hyperscale cloud services such as Microsoft Azure‑based AI applications, Google Cloud’s Vertex AI platform, and LangChain, enabling customers to rapidly build AI apps that securely leverage their unstructured enterprise data, continuously made AI-ready in-place.

 

 

Over the next few months, NetApp AIDE will extend to support an increasing number of deployment options, giving customers broad infrastructure flexibility. AIDE is an integrated set of software solutions that customers will soon be able to run on various server options to help best suit customers’ individual use cases and needs. For example, customers will be able to use NetApp AIDE across their data estate with the new NVIDIA RTX PRO™ 4500 Blackwell Server Edition GPUs announced today at NVIDIA GTC and NVIDIA RTX PRO 6000 Blackwell Server Edition GPUs. NetApp AIDE will also quickly extend to support deployments directly into a wide variety of new and existing NetApp storage environments—including AFF A-Series, AFF C-Series, and FAS.

 

 

And, this summer, NetApp AIDE will add several more capabilities. Expansive hybrid cloud support will bring NetApp AIDE capabilities to enterprise data no matter where it lives—seamlessly across on-premises and cloud storage. NetApp AIDE will also evolve to include new multimodal data capabilities—extending the breadth of NetApp AIDE capabilities to include visual data, unlocking powerful new use cases on a range of unstructured data. And, robust agentic AI support will enable seamless, secure, governed agentic workflows on enterprise data—across a global NetApp data estate—all supporting popular, industry standard protocols.

 

 

“Through our partnership, NetApp and Cisco are delivering enterprise-grade infrastructure that accelerates AI adoption,” said Jeremy Foster, SVP and GM, Cisco Compute. “FlexPod AI—part of the Cisco AI POD portfolio—brings together the full stack of compute, storage, networking, security and observability capabilities our customers need to anchor their AI factories. Using NetApp AIDE with this solution moves AI to our customers’ data, right where it lives, speeding up data pipelines and delivering value faster.”

 

 

To further enhance the NetApp data platform’s ability to support AI innovation, NetApp will support NVIDIA STX, a modular, rack-scale storage reference architecture for agentic AI. Built with NVIDIA Vera Rubin and NVIDIA BlueField-4 DPUs, STX will deliver a high-performance data engine with a specialized memory tier for KV-cache storage, improving power efficiency, throughput, and security. Leveraging NetApp data management capabilities in this new reference architecture, customers will be able to bridge the gap between massive AI compute and unstructured data storage by centralizing intelligent data handling.

 

 

“The fundamental demand for AI factories is pushing enterprises to find new ways to govern and utilize their vast data estates for generating business value,” said Jason Hardy, Vice President, Storage Technologies at NVIDIA. “By integrating with NVIDIA’s AI Data Platform reference architecture, NetApp provides a framework for enterprises to efficiently manage data for large-scale AI deployments.”

 

 

To learn more about NetApp AI Data Engine and NetApp’s collaboration with NVIDIA, visit the NetApp booth at NVIDIA GTC #1907 in San Jose, CA from March 16 -19.

 

 

Additional Resources

 

 

• NetApp AI Data Engine: An End-to-End, Storage-Integrated AI Data Service
• NetApp: The Enterprise-Grade Data Platform for AI
• NetApp and NVIDIA: Bringing the AI Factory to All!

 

About NetApp

 

For more than three decades, NetApp has helped the world’s leading organizations navigate change – from the rise of enterprise storage to the intelligent era defined by data and AI. Today, NetApp is the Intelligent Data Infrastructure company, helping customers turn data into a catalyst for innovation, resilience, and growth.

 

 

At the heart of that infrastructure is the NetApp data platform – the unified, enterprise-grade, intelligent foundation that connects, protects, and activates data across every cloud, workload, and environment. Built on the proven power of NetApp ONTAP, our leading data management software and OS, and enhanced by automation through the AI Data Engine and AFX, it delivers observability, resilience, and intelligence at scale.

 

 

Disaggregated by design, the NetApp data platform separates storage, services, and control so enterprises can modernize faster, scale efficiently, and innovate without lock-in. As the only enterprise storage platform natively embedded in the world’s largest clouds, it gives organizations the freedom to run any workload anywhere with consistent performance, governance, and protection.

 

 

With NetApp, data is always ready – ready to defend against threats, ready to power AI, and ready to drive the next breakthrough. That’s why the world’s most forward-thinking enterprises trust NetApp to turn intelligence into advantage.

 

 

Learn more at www.netapp.com or follow us on X, LinkedIn, Facebook, and Instagram.

 

 

NETAPP, the NETAPP logo, and the marks listed at www.netapp.com/TM are trademarks of NetApp, Inc. Other company and product names may be trademarks of their respective owners.

 

 

 

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260316779334/en/

 

Business Wire India

Cushman & Wakefield (NYSE: CWK), a leading global real estate services firm, has appointed Victoria Lake as Chief Financial Officer (CFO), APAC & EMEA.

 

Lake is a senior executive who joins from Accenture, where she was Deputy CFO of its substantial EMEA business. Her 20 years at Accenture involved serving in multiple leadership roles, including Managing Director, Accenture Corporate Development, leading M&A teams on acquisitions including five sustainability companies. Her experience also includes leading teams and large-scale programs across audit, advisory, client transactions, financial reporting and strategic planning. She began her career at Deloitte.

 

 

At Cushman & Wakefield, Lake will lead all aspects of finance for APAC and EMEA, partnering with regional leadership and global functions to accelerate growth and profitability. Lake, who will be based in London, is a Fellow Chartered Accountant (FCA) with the Institute of Chartered Accountants in England and Wales (ICAEW).

 

 

“I am delighted to welcome Victoria to the firm, and I know she will play an important role in the continued evolution of our finance capabilities,” said Neil Johnston, Global CFO, Cushman & Wakefield. “She is a senior leader who has designed and implemented finance transformations that improve decision-making and drive significant profitable growth and I’m looking forward to her joining our global finance leadership team.”

 

 

“Victoria will bring a depth of experience and expertise that will further accelerate our transformation to a globally integrated and digital enabled platform. This includes a fluency in digital operating models, AI and advanced analytics which will not only drive productivity and efficiency gains for our business but will also help broaden our suite of advanced digital tools for our salesforce, coupled with innovative solutions for our clients,”said Matthew Bouw, Chief Executive, APAC & EMEA, Cushman & Wakefield.

 

 

“Cushman & Wakefield is an excellent cultural and strategic fit and is an organization that shares my passion for connecting data to drive innovation and improved outcomes. I’m looking forward to contributing to its next phase of profitable growth,” said Victoria Lake, CFO, APAC & EMEA, Cushman & Wakefield.

 

 

About Cushman & Wakefield

 

 

Cushman & Wakefield (NYSE: CWK) is a leading global commercial real estate services firm for occupiers and investors with approximately 53,000 employees in over 350 offices and nearly 60 countries. In 2025, the firm reported revenue of $10.3 billion across its core service lines of Services, Leasing, Capital markets, and Valuation and other. Built around the belief that Better never settles, the firm receives numerous industry and business accolades for its award-winning culture. For additional information, visit www.cushmanwakefield.com

 

 

 

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260313711371/en/